PRISM Med Device Index Tech Company Vapotherm, Inc. (VAPO) Announces Fourth Quarter Earnings

New York, February 23, 2024 - PRISM MarketView - PRISM Emerging Med Device Index tech company Vapotherm (VAPO) specializes in the development and commercialization of innovative respiratory support devices. The company is known for its high-flow therapy systems, which deliver heated and humidified breathing gases to patients with respiratory distress. These systems provide a non-invasive alternative to traditional methods such as mechanical ventilation, offering greater comfort and mobility for patients while still delivering effective respiratory support.

The med device emerger announced fourth quarter and fiscal year 2023 financial results reporting a 5.7% increase in Q4 net revenue of $19.7M, 4Q gross margin of 46.6% and cash balance of $9.7M.

Vapotherm, Inc. (OTCQX: VAPO) is a publicly traded developer and manufacturer of advanced respiratory technology based in Exeter, New Hampshire, USA. The Company develops innovative, comfortable, non-invasive technologies for respiratory support of patients with chronic or acute breathing disorders. Over 4.2 million patients have been treated with the use of Vapotherm high velocity therapy® systems. For more information, visit www.vapotherm.com.

Media Contact
Company Name: Prism MarketView
Email: info@prismmarketview.com
Phone: 646-863-6341
Website: https://prismmarketview.com